down arrow

Sichuan Biokin Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100006FN4
CNY
363.95
2.25 (0.62%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sichuan Biokin Pharmaceutical Co., Ltd.
Why is Sichuan Biokin Pharmaceutical Co., Ltd. ?
1
The company has declared Negative results for the last 4 consecutive quarters
  • PRE-TAX PROFIT(Q) At CNY -538.82 MM has Fallen at -110.62%
  • NET PROFIT(Q) At CNY -531.44 MM has Fallen at -110.62%
  • ROCE(HY) Lowest at -42.9%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 52.10%, its profits have risen by 574%
3
Market Beating Performance
  • The stock has generated a return of 52.10% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Sichuan Biokin Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sichuan Biokin Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Sichuan Biokin Pharmaceutical Co., Ltd.
54.94%
1.46
52.29%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
37.00%
EBIT Growth (5y)
149.71%
EBIT to Interest (avg)
68.01
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.56
Tax Ratio
11.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2,080.57%
ROE (avg)
42.59%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
13.44
EV to EBIT
-16.88
EV to EBITDA
-17.61
EV to Capital Employed
13.47
EV to Sales
86.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-79.78%
ROE (Latest)
-74.30%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-44What is not working for the Company
PRE-TAX PROFIT(Q)

At CNY -538.82 MM has Fallen at -110.62%

NET PROFIT(Q)

At CNY -531.44 MM has Fallen at -110.62%

ROCE(HY)

Lowest at -42.9%

OPERATING PROFIT(Q)

Lowest at CNY -575.56 MM

RAW MATERIAL COST(Y)

Grown by 51.17% (YoY

NET SALES(Q)

Lowest at CNY 66.57 MM

INTEREST(Q)

Highest at CNY 15.96 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -864.53 %

Here's what is not working for Sichuan Biokin Pharmaceutical Co., Ltd.
Net Sales
At CNY 66.57 MM has Fallen at -98.78%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY -538.82 MM has Fallen at -110.62%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -531.44 MM has Fallen at -110.62%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Profit
Lowest at CNY -575.56 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (CNY MM)

Net Sales
Lowest at CNY 66.57 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Interest
Highest at CNY 15.96 MM
in the last five periods and Increased by 8.39% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit Margin
Lowest at -864.53 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY -538.82 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Raw Material Cost
Grown by 51.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."